Summary
- Current Price
- As of today, NVS price is $158.18, up +2.35% in the most recent trading session on
- Current Price All-Time High
- NVS price is currently -7.20% below its historical high of $170.46 set on
- Market Cap
- NVS current market cap is $301B, up +24.30% over the past 365 days
- PE Ratio
- NVS current PE ratio is 23.86
- Revenue
- NVS current annual revenue is $54.81B, up +8.99% year-over-year
- Next Earnings
- The next earnings release for NVS is on
Profile
| Metric | Value |
|---|---|
| Full Name | Novartis AG |
| Ticker | NYSE: NVS |
| Exchange | NYSE |
| Sector | Healthcare |
| Industry | General Drug Manufacturers |
| Country | Switzerland |
| IPO | |
| Indexes | Not included |
| Website | novartis.com |
| Employees | 75,883 |
Key Metrics
| Metric | Value | Date |
|---|---|---|
| Price | $158.18 | |
| Price, 1D Change | +2.35% | |
| Market Cap | $301B | |
| TTM Dividend Yield | 3.00% | |
| PE Ratio | 23.86 | |
| Beta | 0.30 | |
| Revenue | $54.81B | |
| Revenue, 1Y Change | +8.99% | |
| EPS | $7.19 | |
| EPS, 1Y Change | +22.60% |
Chart
SUGGESTED SERIES
Events
| Metric | Value | Date |
|---|---|---|
| Next Earnings | ||
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | $4.74 | |
| Next Ex-Dividend | N/A | N/A |
| Last Split | 279:250 | |
| Next Split | N/A | N/A |
| Last Ticker Change | N/A | N/A |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Value | Date |
|---|---|---|
| EPS | $7.19 | |
| EPS Estimate | $8.82 | N/A |
| EPS Est. Change | +22.73% | N/A |
| Revenue | $54.81B | |
| Revenue Estimate | $57.58B | N/A |
| Revenue Est. Change | +5.06% | N/A |
| Current Price | $158.18 | |
| Price Target | $153.58 | - |
| Price Tgt. Change | -2.91% | - |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $7.56 | $5.86 | -22.45% | |
| $8.92 | $7.19 | -19.40% | |
| $8.82 | N/A | +22.73% | |
| $9.87 | N/A | +37.32% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $50.41B | $50.29B | -0.24% | |
| $55.62B | $54.81B | -1.45% | |
| $57.58B | N/A | +5.06% | |
| $61.12B | N/A | +11.52% |
🔒 Log In To Unlock Full Data
Performance
| Metric | Value | Date |
|---|---|---|
| Price, 1Y | +26.59% | |
| Price, 3Y | +56.58% | |
| Market Cap, 1Y | +24.30% | |
| Market Cap, 3Y | +43.90% | |
| Revenue, 1Y | +8.99% | |
| Revenue, 3Y | +29.61% | |
| EPS, 1Y | +22.60% | |
| EPS, 3Y | +126.67% |
🔒 Log In To Unlock Full Data
Technicals
| Metric | Value | Date |
|---|---|---|
| Current Price | $158.18 | |
| SMA 200 | $147.72 | |
| SMA 50 | $153.69 | |
| EMA 200 | $146.39 | |
| EMA 50 | $153.44 | |
| MACD | -$0.29 | |
| Beta | 0.30 | |
| ATR | $2.77 | |
| 14-Day RSI | 51.33 | |
| 10-Day Volatility | 17.12% |
Dividends
| Metric | Value | Date |
|---|---|---|
| Last Paid | $4.74 | |
| Upcoming | N/A | N/A |
| Dividend Yield | 2.52% | |
| Total Dividend | $3.99 | |
| Dividends Paid | $7.86B | |
| Payout Ratio | 55.97% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Value | Date |
|---|---|---|
| Revenue | $54.81B | |
| EPS | $7.19 | |
| Gross Profit | $41.04B | |
| Gross Margin | 74.88% | |
| Operating Income | $16.47B | |
| Operating Margin | 30.05% | |
| Net Income | $14.04B | |
| Net Margin | 25.61% | |
| EBITDA | $21.82B |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Value | Date |
|---|---|---|
| Debt To Equity | 0.77 | |
| Current Ratio | 1.12 | |
| Quick Ratio | 0.89 | |
| - | ||
| Piotroski F-Score | 6 | |
| Altman Z-Score | 4.14 |
Valuations
Balance Sheet
| Metric | Value | Date |
|---|---|---|
| Book Value | $46.13B | |
| Cash & Equivalents | $11.59B | |
| Total Assets | $115.57B | |
| Current Assets | $30.46B | |
| Total Liabilities | $69.02B | |
| Current Liabilities | $27.28B | |
| Total Debt | $35.46B | |
| Short Term Debt | $5.87B | |
| Accounts Payable | $4.46B |
Expenses
| Metric | Value | Date |
|---|---|---|
| Total Expenses | $40.76B | |
| Operating Expenses | $24.57B | |
| Cost Of Goods Sold | $13.77B | |
| SG&A | $0.00 | |
| D&A | $5.35B | |
| Interest Expense | $0.00 | |
| Income Tax | $2.40B |
Cash Flow
| Metric | Value | Date |
|---|---|---|
| CFO | $19.24B | |
| CFI | -$4.90B | |
| CFF | -$14.94B | |
| Capex | $3.92B | |
| Free Cash Flow | $15.32B |
Recent analyst updates
| Metric | Value | Date |
|---|---|---|
| Morgan Stanley | → | |
| Barclays | → | |
| JP Morgan | → | |
| Goldman Sachs | → | |
| UBS | → | |
| Erste Group | → | |
| BMO Capital | → | |
| B of A Securities | → | |
| Goldman Sachs | → | |
| Jefferies | → |
Analyst sentiment
Institutional ownership
Screeners with NVS
FAQ
- What is the ticker symbol for Novartis AG?
- The ticker symbol for Novartis AG is NYSE:NVS
- Does Novartis AG pay dividends?
- Yes, Novartis AG pays dividends. The last payment was $4.74, with an ex-dividend date on March 11, 2026
- What sector is Novartis AG in?
- Novartis AG is in the Healthcare sector
- What industry is Novartis AG in?
- Novartis AG is in the General Drug Manufacturers industry
- What country is Novartis AG based in?
- Novartis AG is headquartered in Switzerland
- When did Novartis AG go public?
- Novartis AG initial public offering (IPO) was on November 7, 1996
- Is Novartis AG in the S&P 500?
- No, Novartis AG is not included in the S&P 500 index
- Is Novartis AG in the NASDAQ 100?
- No, Novartis AG is not included in the NASDAQ 100 index
- Is Novartis AG in the Dow Jones?
- No, Novartis AG is not included in the Dow Jones index
- When was Novartis AG last earnings report?
- Novartis AG's most recent earnings report was on July 21, 2026
- When does Novartis AG report earnings?
- The next expected earnings date for Novartis AG is October 27, 2026
Data Sources & References
- NVS Official Website www.novartis.com
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1114448/000111444826000004/0001114448-26-000004-index.htm
- NVS Profile on Yahoo Finance finance.yahoo.com/quote/NVS
- NVS Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/nvs
